SynthesisFrontiers in immunology2025

Effectiveness and safety of teclistamab for relapsed or refractory multiple myeloma: a systematic review and meta-analysis.

Wenze Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.